Tech Company Financing Transactions
CSA Medical Funding Round
On 1/26/2011, CSA Medical announced $10 million in Series A investment from New Markets Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
1/26/2011
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
New Markets Venture Partners (Lead Investor)
Proceeds Purpose
The Series A Financing eliminated all debt and brings the total investment in our novel, energy-based spray cryotherapy system to $32 million to date.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
91 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Our truFreeze spray cryotherapy technology uses extremely cold liquid nitrogen (-196° C) to provide targeted, touchless ablation of unwanted tissue inside the body under direct visualization. The truFreeze System can be used in general surgery with or without an endoscope.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ellen Sheets
VP - Engineering
John O'Connor
VP - Marketing
Teresa Prego
VP - R & D
Brian Hanley
VP - R & D
Ann Murphy-Legg
VP - Regulatory Affairs
Sherrie Coval-Goldsmith
Browse more venture capital transactions:
Prev: 1/26/2011: Appmobi venture capital transaction
Next: 1/26/2011: Korrio venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs